As of 2026-09-09, the Relative Valuation of G1 Therapeutics Inc (GTHX) is (17.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.15 USD, the upside of G1 Therapeutics Inc based on Relative Valuation is -350.7%.
The range of the Relative Valuation is (16.63) - (20.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.6x - 24.3x | 22.0x |
| Forward P/E multiples | 16.2x - 24.4x | 20.3x |
| Fair Price | (16.63) - (20.62) | (17.92) |
| Upside | -332.6% - -388.4% | -350.7% |
| Date | P/E |